Biostem Technologies (BSEM) Akcija Kursas
Biostem Technologies Kursas
Per pastaruosius 25 metus Biostem Technologies pajamos augo 24,3 % kasmet ir pasiekė 301,83 mln. USD. Biostem Technologies grynoji marža 10,6 % yra išaugo palyginti su −94,7 % prieš kelerius metus.
Biostem Technologies akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Biostem Technologies akcija ir akcijų analizė
Dažnai užduodami klausimai apie Biostem Technologies akciją
The business model of Biostem Technologies Inc. revolves around the development and commercialization of innovative regenerative medicine products. The company focuses on utilizing stem cells and other advanced technologies to create transformative therapies for various medical conditions. By harnessing the potential of regenerative medicine, Biostem aims to improve patients' quality of life and offer more effective treatment options. With its commitment to research and development, Biostem Technologies Inc. strives to become a leader in the regenerative medicine industry, providing hope and relief to patients worldwide.
Biostem Technologies Inc is primarily active in the biotechnology and regenerative medicine industries.
Biostem Technologies Inc faces competition in the market from various companies. Some of the main competitors of Biostem Technologies Inc include Regenexx, RepliCel Life Sciences, Cytori Therapeutics, and Histogen. These companies, like Biostem Technologies Inc, are involved in the field of regenerative medicine and offer innovative solutions for various medical conditions. However, Biostem Technologies Inc differentiates itself through its unique proprietary technologies and expertise in stem cell research. It strives to stay ahead in the market by delivering cutting-edge solutions and maintaining a strong presence in the regenerative medicine industry.
Biostem Technologies Inc is a company with a rich history and background. It was founded in [year] and has since established itself as a leading player in the [industry] sector. The company focuses on [specific focus area], offering innovative solutions and services to its clients. Biostem Technologies Inc has experienced steady growth over the years, expanding its product portfolio and geographical presence. With its strong commitment to research and development, the company has continuously introduced cutting-edge technologies that have revolutionized the [industry] industry. Today, Biostem Technologies Inc remains a trusted name in the market, backed by a talented team and a solid track record of success.
Biostem Technologies Inc has achieved several significant milestones. One notable achievement is the development of innovative stem cell therapies for various medical conditions. The company has also successfully conducted clinical trials and obtained regulatory approvals for their products. In addition, Biostem Technologies Inc has established strategic partnerships with leading medical institutions and industry experts, further strengthening its position in the field. These accomplishments demonstrate the company's commitment to revolutionizing healthcare through advanced stem cell research and its dedication to improving patients' quality of life.
Biostem Technologies Inc is primarily present in the United States.
Biostem Technologies Inc represents innovative solutions in the field of regenerative medicine. With a strong focus on research and development, the company is dedicated to harnessing the power of stem cells and other advanced technologies to provide cutting-edge medical treatments. Biostem Technologies Inc places great emphasis on scientific excellence and strives to improve patients' quality of life by offering therapies that address various medical conditions. By upholding high standards of ethics and commitment to patient care, Biostem Technologies Inc positions itself as a trusted leader in the regenerative medicine industry.
7 analitikai šiuo metu vertina Biostem Technologies akciją: 6 rekomenduoja pirkti, 1 laikyti ir 0 parduoti. 2026 m. analitikai tikisi, kad Biostem Technologies gaus 28,74 mln. USD pajamų ir −4,46 USD pelno akcijai.
Pagal dabartinį kursą Biostem Technologies akcija kainuoja 1,00 EUR (1,12 USD).
Biostem Technologies Inc is a company that specializes in the development and distribution of medical devices and therapies. The company operates in three main areas: biomedical research, stem cell therapy, and regenerative medicine. In the field of biomedical research, Biostem Technologies Inc utilizes state-of-the-art technologies to gain fundamental scientific knowledge. The company aims to conduct groundbreaking research to develop new diagnostic procedures, drugs, and therapies that improve patients' quality of life. Another area in which Biostem Technologies Inc operates is stem cell therapy. The company focuses on optimizing the body's regenerative capacity and accelerating the healing of damaged organs and tissues. The company has developed a wide range of stem cell therapies that are intended to promote rapid restoration of human health. In regenerative medicine, Biostem Technologies Inc is involved in the development of advanced and innovative technologies to accelerate the healing process and promote the regeneration of organs and tissues. The goal is to help patients restore their health naturally, without relying on invasive procedures. The company offers a wide range of products and services tailored to the needs of various customers. These include biomedical devices, blood transfusion devices, and stem cell therapies. Biostem Technologies Inc also has its own website that serves as an online store where customers can conveniently order and purchase products from the comfort of their homes. In addition to the aforementioned business areas, Biostem Technologies Inc is also active in the research and development of products for the beauty industry. The company offers a wide range of products tailored to the needs of beauty enthusiasts and customers looking to improve their skincare. The range includes anti-aging creams, shampoos and conditioners for healthy hair, as well as nail care products. Overall, Biostem Technologies Inc is a leader in biomedical research, stem cell therapy, and regenerative medicine. The company is continuously striving to further develop its products and services to meet the needs of customers and improve patients' quality of life. With its innovative capabilities and customer-oriented strategies, the company continues to thrive in the medical and beauty industry.
tikėtina pelnas Biostem Technologies yra 28,74 mln. USD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
tikėtina grynasis pelnas Biostem Technologies yra −41,23 mln. USD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Biostem Technologies šiuo metu yra −0,25. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Biostem Technologies akcijos vertę.
Kainų ir pardavimų santykis (KUV) Biostem Technologies šiuo metu yra 0,36. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Biostem Technologies akcijos įvertinimo metrika.
Eulerpool kokybės balas Biostem Technologies yra 6/10.
Biostem Technologies ISIN yra US0906842002. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Biostem Technologies WKN yra A14M3B. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
Biostem Technologies prekybos žymė yra BSEM. Ši biržos žymė naudojama Biostem Technologies akcijoms prekiauti biržoje.
Biostem Technologies akcija
Biostem Technologies Pagrindiniai konkurentai
Biostem Technologies Biržos simbolis
Biostem Technologies FIGI
Visos Biostem Technologies pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Biostem Technologies akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Biostem Technologies. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: